USMLE Step 1 practice question: Lambert-Eaton myasthenic syndrome as a paraneoplastic syndrome of small cell lung cancer
USMLE Step 1RespiratoryPathology
Which of the following is the most likely cause of this patient's weakness?
- Antibodies against presynaptic voltage-gated calcium channels
- Antibodies against postsynaptic nicotinic acetylcholine receptors
- Myopathy caused by ectopic tumor secretion of corticotropin
- Antineuronal (anti-Hu) antibodies damaging dorsal root ganglia
- Hypercalcemia from tumor secretion of PTH-related peptide
Show answer and explanation
Correct answer: A. Antibodies against presynaptic voltage-gated calcium channels
This heavy smoker with weight loss and a central (hilar) lung mass most likely has small cell lung carcinoma (SCLC). His proximal weakness that improves transiently with sustained effort, absent reflexes that reappear after brief exercise (post-exercise facilitation), autonomic dysfunction (dry mouth, constipation, erectile dysfunction), and an incremental response to high-frequency repetitive nerve stimulation are diagnostic of Lambert-Eaton myasthenic syndrome (LEMS), a paraneoplastic disorder of the neuromuscular junction.
SCLC arises from neuroendocrine (Kulchitsky) cells that express P/Q-type voltage-gated calcium channels (VGCCs). Antibodies generated against tumor VGCCs cross-react with identical channels on presynaptic motor nerve terminals (and autonomic nerve terminals), a type II hypersensitivity reaction. Fewer functioning channels reduce Ca²⁺ influx with each action potential, so fewer acetylcholine-containing vesicles are released and endplate potentials often fail to reach threshold, causing weakness and hyporeflexia. With sustained contraction or rapid (20–50 Hz) stimulation, Ca²⁺ accumulates in the nerve terminal and transiently increases acetylcholine release—hence the improvement with effort and the incremental response. About half of LEMS cases are paraneoplastic, nearly all from SCLC, and LEMS may precede detection of the tumor.
Treatment targets the tumor; symptomatic therapy uses amifampridine (3,4-diaminopyridine), which blocks presynaptic K⁺ channels, prolonging depolarization and increasing Ca²⁺ entry and acetylcholine release. Other SCLC paraneoplastic syndromes include SIADH, ectopic ACTH secretion (Cushing syndrome), and anti-Hu–associated encephalomyelitis and sensory neuronopathy; squamous cell carcinoma secretes PTH-related peptide.
High-yield summary: LEMS = antibodies to presynaptic P/Q-type VGCCs, proximal weakness that improves with use, hyporeflexia with post-exercise facilitation, autonomic symptoms, and an incremental response; associated with SCLC. Myasthenia gravis = antibodies to postsynaptic AChRs, fatigable weakness that worsens with use, prominent ocular and bulbar signs, normal reflexes, and a decremental response; associated with thymoma.
Why the other options are wrong
- B. Antibodies against postsynaptic nicotinic acetylcholine receptors — Antibodies to postsynaptic acetylcholine receptors cause myasthenia gravis, in which weakness worsens with repeated use, ocular and bulbar muscles are prominently involved, reflexes are preserved, autonomic function is normal, and repetitive stimulation shows a decremental response; it is associated with thymoma.
- C. Myopathy caused by ectopic tumor secretion of corticotropin — Ectopic ACTH secretion by SCLC can cause a proximal glucocorticoid-induced myopathy, but it typically produces hypokalemia, metabolic alkalosis, hyperglycemia, and hypertension and does not cause hyporeflexia with post-exercise facilitation or autonomic dysfunction.
- D. Antineuronal (anti-Hu) antibodies damaging dorsal root ganglia — Anti-Hu antibodies associated with SCLC cause paraneoplastic encephalomyelitis and sensory neuronopathy (dorsal root ganglionitis), producing sensory loss and sensory ataxia; this patient has intact sensation and a pure motor-autonomic disorder of neuromuscular transmission.
- E. Hypercalcemia from tumor secretion of PTH-related peptide — PTH-related peptide–mediated hypercalcemia is characteristic of squamous cell lung carcinoma and causes weakness, fatigue, constipation, and confusion; this patient's serum calcium concentration is normal.
Key point
Lambert-Eaton myasthenic syndrome, a paraneoplastic complication of small cell lung cancer, is caused by antibodies against presynaptic voltage-gated calcium channels that reduce acetylcholine release.
Memory hook
Lambert-Eaton: Lifting Eases it — weakness improves with use, presynaptic Ca²⁺ channels blocked, think small cell. Myasthenia: worse with use, postsynaptic AChR.
15 free bank questions a day, exam-length timed blocks, spaced repetition and 3D anatomy — in English and Russian.
Play free